Jordan Laser, MD, FCAP, and chair of the CAP Personalized Health Care Committee, discusses a recent CAP article that highlights how exosomes are expanding the power of liquid biopsy in cancer diagnosis even further. “Exosomes provide access to far more genetic and non-genetic material than has previously been available for diagnostics,” said Dr. Laser.
For the full article click here: Exosomes Break the Liquid Biopsy Barrier